Panelists discuss how the evolution of anal cancer treatment began with the 1974 Nigro regimen combining 5-fluorouracil and ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796 Provided by GlobeNewswire Jun 4, 2025, 4:00:00 AM ...

Philadelphia, PA, June 4, 2025 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic inflammatory diseases through selective modulation of the NLRP3 ...

In a collaboration aimed at reshaping access to early phase oncology trials, The START Center for Cancer Research (START) and OneOncology have announced the launch of 3 new early-phase clinical trial ...

Quiver AI Summary Invivyd, Inc. announced the publication of results from its CANOPY Phase 3 clinical trial of pemivibart, a monoclonal antibody aimed at preventing symptomatic COVID-19.

The global, single-arm, multi-center Phase 2 pivotal trial evaluates the efficacy and safety of RP-A501 in 12 patients with Danon disease, including a pediatric safety run-in (n=2), and a dose ...

The goals of a Phase 2 clinical trial are to determine if the treatment is effective and to gather more safety data. Researchers use the data from Phase 2 trials to refine their research questions ...

The Phase 3 AFFIRM-AL clinical trial was a global, double-blind, placebo-controlled, time-to-event clinical trial that enrolled 207 newly diagnosed, treatment naïve patients with Mayo Stage IV AL ...

Endeavor continues to study ENV-101 and has initiated the Phase 2b WHISTLE-PF (W ound-remodeling H edgehog-Inhibitor I LD S tudy T esting L ung Function E ndpoints- PF) clinical trial, a global ...

A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment expected in September. Six patients are left to complete the 25-patient enrollment ...